Viewing StudyNCT02150967



Ignite Creation Date: 2024-05-06 @ 2:54 AM
Last Modification Date: 2024-10-26 @ 11:25 AM
Study NCT ID: NCT02150967
Status: TERMINATED
Last Update Posted: 2023-07-03
First Post: 2014-05-12

Brief Title: A Phase II Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Sponsor:
Organization: QED Therapeutics Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 143
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: